by Team Small News | Apr 15, 2025 | Glenmark, Pharma, Sun Pharma, Zydus
Three major Indian pharmaceutical companies, Sun Pharma, Zydus, and Glenmark, have issued recalls of their products in the United States due to manufacturing issues. The recalls were announced by the US Food and Drug Administration (FDA) and cover a range of products,... by Team Small News | Apr 12, 2025 | Pharma, Sun Pharma
Karishma Shanghvi is a remarkable individual who is making a significant impact in the corporate social responsibility (CSR) projects at Sun Pharma, one of India’s largest pharmaceutical companies, with a market value of over Rs. 4.5 lakh crore. As the... by Team Small News | Apr 10, 2025 | Pharma, Sun Pharma
Sun Pharma has successfully removed an injunction in the US that was blocking the launch of its hair loss treatment, Leqselvi, for alopecia areata. The company had been facing a lawsuit from rival Incyte, which claimed that Leqselvi infringed on its patents for its... by Team Small News | Apr 9, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Zydus
The US government, under President Donald Trump, has announced plans to impose new tariffs on pharmaceutical imports, which could significantly impact India, the top supplier of generic drugs to the US. The move aims to push pharmaceutical manufacturing back to the... by Team Small News | Apr 9, 2025 | Pharma, Sun Pharma
Indian pharmaceutical company Sun Pharmaceutical Industries has launched Fexuclue, a novel potassium-competitive acid blocker (PCAB) for the treatment of erosive esophagitis in adults. The medication, manufactured under an agreement with South Korean biopharmaceutical... by Team Small News | Apr 8, 2025 | Pharma, Sun Pharma
Here is a summary of the content in 400 words: Sun Pharmaceutical Industries, a Mumbai-based company, has launched a new drug called Fexuclue in India, which is a potassium competitive acid blocker (PCAB) designed to treat adults with Erosive Esophagitis of all...